Cor Vasa 2013, 55(6):e487-e491 | DOI: 10.1016/j.crvasa.2013.07.005

The relationship between eosinophil and nondipper hypertension

Mustafa Kuzeytemiz, Mehmet Demir*, Muhammed Şentürk
Kardiologická klinika, Bursa Yüksek İhtisas Education and Research Hospital, Bursa, Turecko

Aims: Nondipper hypertension is associated with increased cardiovascular morbidity and mortality. It is known that eosinophils play an important role in vasoconstriction and thrombosis. We aimed to compare the numbers of eosinophil counts of the patients with nondipper versus dipper hypertension.
Materials and method: This study included 70 hypertensive patients. Hypertensive patients were divided into two groups: 35 dipper patients (15 males, mean age 50.94 ± 11.13 years) and 35 nondipper patients (10 males, mean age 56.11 ± 11.05 years). Concurrent routine biochemical tests and eosinophil count on whole blood count were performed on these patients. These parameters were compared between groups.

Results: No statistically significant difference was found between two groups in terms of basic characteristics. Baseline characteristics of the study groups were comparable. Nondipper patients had a higher eosinophil and MPV value than dipper patients (148.86 ± 80 vs 304.57 ± 182 and 7.8 ± 0.12 vs 9.2 ± 0.2 fl, p < 0.001, respectively).

Conclusion: Eosinophil count and MPV value are higher in patients with nondipper hypertension when compared to the dippers.

Keywords: Eosinophil; Mean platelet volume; Nondipper hypertension; Thrombosis; Vasospasm

Received: July 1, 2013; Revised: July 13, 2013; Accepted: July 23, 2013; Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuzeytemiz M, Demir M, Şentürk M. The relationship between eosinophil and nondipper hypertension. Cor Vasa. 2013;55(6):e487-491. doi: 10.1016/j.crvasa.2013.07.005.
Download citation

References

  1. K. Shimada, A. Kawamoto, K. Matsubayashi, et al., Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension, Journal of Hypertension 10 (1992) 875-878. Go to PubMed...
  2. H.S. Seo, T.S. Kang, S. Park, et al., Non-dippers are associated with adverse cardiac remodeling and dysfunction, International Journal of Cardiology 112 (2006) 171-177. Go to original source... Go to PubMed...
  3. H. Sasano, R. Virmani, R.H. Patterson, et al., Eosinophilic products lead to myocardial damage, Human Pathology 20 (1989) 850-857. Go to original source... Go to PubMed...
  4. J. Wang, S.A. Mahmud, J.A. Thompson, et al., The principal eosinophil peroxidase product. HOSCN is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states, Blood 107 (2006) 558-565. Go to original source... Go to PubMed...
  5. M.S. Rohrbach, C.L. Wheatley, N.R. Slifman, G.J. Gleich, Activation of platelets by eosinophil granule proteins, Journal of Experimental Medicine 172 (1990) 1271-1274. Go to original source... Go to PubMed...
  6. E.G. Olsen, C.J. Spry, Relation between eosinophils and endomyocardial disease, Progress in Cardiovascular Diseases 27 (4) (1985) 241-254. Go to original source...
  7. M. Fukuda, M. Munemura, T. Usami, et al., Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy, Kidney International 65 (2004) 621-625. Go to original source... Go to PubMed...
  8. T. Ohkubo, A. Hozawa, J. Yamaguchi, et al., Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study, Journal of Hypertension 20 (2002) 2183-2189. Go to original source... Go to PubMed...
  9. M. Demir, The relationship between neutrophil lymphocyte ratio and non-dipper hypertension, Clinical and Experimental Hypertension (2013) (Epub ahead of print). Go to original source... Go to PubMed...
  10. A. Myredal, P. Friberg, M. Johansson, Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern, American Journal of Hypertension 23 (3) (2010) 255-259. Go to original source... Go to PubMed...
  11. S. Umemoto, N. Suzuki, K. Fujii, et al., Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris, American Journal of Cardiology 85 (6) (2000) 715-719. Go to original source... Go to PubMed...
  12. O. Erdogan, C. Gul, A. Altun, G. Ozbay, Increased immunoglobulin E response in acute coronary syndromes, Angiology 54 (1) (2003) 73-79. Go to original source... Go to PubMed...
  13. E. Yilmaz, S. Güven, O. Kocaman, E. Kiyan, Acute severe myocarditis in a woman hypereosinophilic syndrome, Türk Kardiyoloji Dernegi Arşivi 30 (2002) 214-217.
  14. T. Inanc, M.G. Kaya, M. Yarlioglues, et al., The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives, Blood Pressure 19 (2) (2010) 81-85. Go to original source... Go to PubMed...
  15. C. Moosbauer, E. Morgenstern, S.L. Cuvelier, et al., Eosinophils area major intravascular location for tissue factor storage and exposure, Blood 109 (3) (2007) 995-1002. Go to original source... Go to PubMed...
  16. R.M. Ten, L.R. Pease, D.J. McKean, et al., Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family, Journal of Experimental Medicine 169 (5) (1989) 1757-1769. Go to original source...
  17. M. Levi, C.E. Hack, J.P. de Boer, et al., Reduction of contact activation related fibrinolytic activity in Factor XII deficient patients. Further evidence for the role of the contact system on fibrinolysis in vivo, Journal of Clinical Investigation 88 (4) (1991) 1155-1160. Go to original source... Go to PubMed...
  18. F. Rodeghiero, G. Castaman, M. Ruggeri, et al., Fibrinolytic studies in 13 unrelated families with factor XII deficiency, Haematologica 76 (1) (1991) 28-32. Go to PubMed...
  19. P.R. Ames, M. Margaglione, S. Mackie, J.D. Alves, Eosinophilia and thrombophilia in Churg Strauss Syndrome: a clinical and pathogenetic overview, Clinical and Applied Thrombosis/Hemostasis 16 (6) (2010) 628-636. Go to original source... Go to PubMed...
  20. A. Slungaard, G.M. Vercellotti, T. Tran, et al., Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease, Journal of Clinical Investigation 91 (4) (1993) 1721-1730. Go to original source... Go to PubMed...
  21. T. Sakai, S. Inoue, T.A. Matsuyama, et al., Eosinophils may be involved in thrombus growth in acute coronary syndrome, International Heart Journal 50 (3) (2009) 267-277. Go to original source... Go to PubMed...
  22. S. Yoshikawa, S.G. Kayes, J.C. Parker, Eosinophils increase lung microvascular permeability via the peroxidase-hydrogen peroxide-halide system. Bronchoconstriction and vasoconstriction unaffected by eosinophil peroxidase inhibition, American Review of Respiratory Disease 147 (4) (1993) 914-920. Go to original source... Go to PubMed...
  23. G. Niccoli, D. Schiavino, F. Belloni, et al., Preintervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents, European Heart Journal 30 (11) (2009) 1340-1347. Go to original source... Go to PubMed...
  24. M. Joner, A.V. Finn, A. Farb, et al., Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk, Journal of the American College of Cardiology 48 (2006) 193-202. Go to original source... Go to PubMed...
  25. C. Yutani, H. Ishibashi-Ueda, T. Suzuki, A. Kojima, Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis, Cardiology 92 (1999) 171-177. Go to original source... Go to PubMed...
  26. S. Keçeoğlu, M. Demir, U. Uyan, M. Melek, The effects of eosinophil on the left atrial thrombus in patients with atrial fibrillation, Clinical and Applied Thrombosis/Hemostasis (2013) (Epub ahead of print). Go to original source...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.